Pharmacological treatment of psychotic depression.

Completed

• Registration Number: NL-OMON24572

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 160

Inclusion Criteria

1. Age 18-65;

2. Major depressive disorder, single or recurrent episode, with psychotic features (Diagnostic and Statistical Manual of Mental Disorders, Fourth edition [DSM IV]);

Exclusion Criteria

1. Bipolar I or II disorder;

2. Schizophrenia or other primary psychotic disorder;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of responders.

Secondary Outcome Measures

Name	Time	Method
1a. Change in HRSD scores;<br /><br>1b. Change in CGI scores;<br /><br>2. Time to response;<br /><br>3. Adverse effects;<br /><br>4. Group differences especially with regard to response to earlier treatments during current episode.